Smart sensors could help Parkinson's patients spend less time 'Off'

NCT ID NCT07074119

Not yet recruiting Symptom relief Sponsor: Assistance Publique - Hôpitaux de Paris Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether wearable body sensors can help doctors better adjust medication for people with Parkinson's disease who experience motor fluctuations. 218 participants will wear the sensors for 7 days before each visit, and only the experimental group's data will guide treatment changes. The goal is to reduce the daily time spent in the 'OFF' state (when symptoms return) over 6 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: wearable body-worn sensors (BWS) for monitoring motor symptoms
What this could lead to: If successful, this could provide a new, data-driven way for doctors to fine-tune Parkinson's medication remotely, reducing time spent with poor symptom control.
What could go wrong: This is an early-stage study with no prior randomized evidence for this approach. The sensors may not capture real-life conditions accurately, and results may not lead to widespread use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARKINSON DISEASE (PD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Dyskinesias Hypokinesia Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PARKINSON DISEASE (PD)

Contacts and locations

Locations

Centre d'investigations cliniques Pitié-Salpêtrière University Hospital

Paris, Île-de-France Region, 75013, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.